Immune cell boost after transplant shows promise against leukemia
NCT ID NCT05015426
First seen Nov 14, 2025 · Last updated Jun 13, 2026 · Updated 26 times
Summary
This early-phase trial tests whether a single infusion of specially grown donor immune cells (γδ T-cells) can help prevent acute myeloid leukemia from coming back in patients who had a stem cell transplant. About 20 adults aged 18-75 at high risk of relapse will receive increasing doses to find the safest and most effective amount. The study focuses on safety, survival without leukemia, and overall survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.